MOMehdi Oualha

Mehdi Oualha

*This is an algorithmically generated author record based on publicly available information.

Mehdi Oualha has a total of 247 co-authors. Here are the top co-authors by number of shared publications:

  • Sylvain Renolleau

    Department of Pediatric Intensive Care Necker‐Enfants Malades Hospital, AP‐HP.Centre, Université Paris Cité Paris Ile‐de‐France France

    10 shared publications
  • Sihem Benaboud

    Department of Clinical Pharmacology Cochin Hospital Paris Ile‐de‐France France

    9 shared publications
  • Sylvain Renolleau

    Réanimation Et Surveillance Continue Médico-Chirurgicales Pédiatriques, Hôpital Necker-Enfants Malades, AP-HP, Université de Paris, Paris, France

    9 shared publications
  • Agathe Béranger

    Université Paris Cité, Inserm, UMR1343, Pharmacologie et Évaluations des Thérapeutiques Chez l'Enfant et la Femme Enceinte, Paris, France

    8 shared publications
  • Jean-Marc Treluyer

    Department of Clinical Pharmacology Cochin Hospital Paris Ile‐de‐France France

    8 shared publications
  • Emmanuelle Bille

    Department of Clinical Microbiology Necker‐Enfants Malades Hospital, APHP Paris Ile‐de‐France France

    7 shared publications

Latest Publications

  • Open Access

    Cefepime exposure in prolonged or intermittent infusion in critically ill children

    by Marc Hobeika, Deborah Hirt, Emmanuelle Bille, Sihem Benaboud, Julie Toubiana, Pierre‐Louis Léger, Jérôme Rambaud, Agathe Béranger, Delphine Callot, Sylvain Renolleau, et al.

    Aims: Cefepime is commonly used in critically ill children for whom there is a high between‐subject variability. To reach the therapeutic pharmacokinetic (PK) target in critically ill patients, prolonged infusion of beta‐lactams seems to be the most efficient. The aim of this study was to compare cefepime exposure between prolonged and intermittent infusions in critically ill children. Methods: This prospective observational study was conducted in two paediatric intensive care units. Children with a cefepime plasma concentration measurement were included. Steady‐state free residual and plateau concentrations were estimated using Bayesian forecasting. The PK target was defined as 100% f T ≥4xMIC . Exposure was compared using the minimum inhibitory concentrations (MICs) of the pathogens identified in the patients. The probability of target attainment (PTA) was also compared using various MICs. Results: Seventy‐eight antibiotic courses in 75 patients were included, divided into 19 prolonged infusions and 59 intermittent infusions. Prolonged and intermittent infusions were comparable for optimal exposure ( n = 10/19, 53% vs. n = 35/59, 59%, p = .79). Overexposure tended to be more frequent with prolonged infusion ( n = 8/19, 42% vs. n = 16/59, 27%, p = .26), whereas underexposure tended to be less common with prolonged infusion ( n = 1/19, 5% vs. n = 8/59, 14%, p = .44). Considering the wide range of MICs, the PTA was comparable for MIC < 1 mg/L but was significantly higher for prolonged infusion for MIC ≥ 1 mg/L ( p < .05). Conclusion: Prolonged infusion of cefepime provides a higher PTA when MIC is ≥1 mg/L compared with intermittent infusion. This result suggests the superiority of prolonged infusion for high MIC bacteria.


  • Piperacillin Population Pharmacokinetics in Children Supported With Extracorporeal Membrane Oxygenation

    by Adrien Arsène, Mehdi Oualha, Jérôme Rambaud, Sihem Benaboud, Saik Urien, Marion Grimaud, Sylvain Renolleau, Pierre-Louis Léger, Déborah Hirt, Jean-Marc Tréluyer, et al.

    OBJECTIVE: To characterize piperacillin population pharmacokinetics (PK) in critically ill children with and without extracorporeal membrane oxygenation (ECMO) support and to optimize piperacillin dosing regimens to attain the PK target of 100% free time above minimum inhibitory concentration (fT > minimum inhibitory concentration). DESIGN: Post hoc secondary analysis of a two-center, population PK modeling and simulation study (registered at clinicaltrials.gov, NCT02539407). SETTINGS: PICUs at tertiary care centers, September 2015–November 2021. PATIENTS: Thirty-three children supported with ECMO and 50 non-ECMO control patients treated with piperacillin (± tazobactam). INTERVENTIONS: Administration of piperacillin at 300 mg/kg/d by continuous infusion or 75 mg/kg every 6 hours by intermittent infusion. MEASUREMENTS AND MAIN RESULTS: A one-compartment linear-elimination model described best the piperacillin data. Clearance was driven by body weight and estimated glomerular filtration rate (eGFR). In a typical 11-kg patient, ECMO circuit volume-to-weight ratio increased the volume of distribution by 34%. Monte Carlo simulations across eGFR strata (30–60, 60–90, 90–150, 150–200, 200–300 mL/min/1.73 m 2 ) showed that a continuous infusion of 300 mg/kg/d allowed greater than or equal to 90% of target attainment in all groups. Patients with an eGFR greater than 200 mL/min/1.73 m 2 required 400 mg/kg/d to have 90% of target attainment. CONCLUSIONS: Continuous infusion of 300 mg/kg/d piperacillin reliably achieves PK target across all renal‐function ranges in children undergoing support with ECMO. Dose escalation to 400 mg/kg/d is required for augmented renal clearance (eGFR > 200 mL/min/1.73 m 2 ).

  • Open Access

    Corrigenda: Pain, Agitation, Delirium, and Iatrogenic Withdrawal Syndrome Management in Children Who Are Critically Ill: Protocol for a European Clinical Practice Guideline Using the Grading of Recommendations Assessment, Development, and Evaluation Approach

    by Ibo MacDonald, Alexia Cavin-Trombert, Cécile Jaques, Gwenaëlle De Clifford-Faugère, Pieter A De Cock, Saskia N de Wildt, Dmytro Dmytriiev, Juliane Engel, Paola Claudia Fazio, Sylvia George, et al.

    [This corrects the article DOI: 10.2196/67930.].

  • Piperacillin Population Pharmacokinetics in Plasma and Peritoneal Fluid and Dosing Optimization in Children Undergoing Liver Transplant: An Optimome Study

    by Noémie de Cacqueray, Mehdi Oualha, Frantz Foissac, Leo Froelicher Bournaud, Gabrielle Lui, Emmanuelle Bille, Christophe Chardot, Carmen Capito, Florence Lacaille, Philippine Widmer, et al.

    Piperacillin–tazobactam is frequently used in children undergoing liver transplantation (LT), yet its pharmacokinetics (PK) in this population remains poorly characterized. We aimed to develop a population pharmacokinetic model for piperacillin in plasma and peritoneal fluid in children undergoing LT and to optimize dosing regimen for this population. We conducted a retrospective, single‐center, observational study including all children receiving piperacillin–tazobactam as prophylaxis for LT and had at least one piperacillin concentration in both plasma and peritoneal fluid. PK analysis was conducted using nonlinear mixed effect modeling (Monolix) and was part of Optimome study. We included 31 patients with a median (range) age of 4 years (4 months–17 years). A total of 172 plasma and 146 peritoneal fluid samples were analyzed. Plasma concentrations were best fitted by a one‐compartment model with first‐order elimination. A virtual effect site compartment was added to adequately describe piperacillin concentrations in plasma and peritoneal fluid. Allometrically scaled body weight (pre‐transplant and current values) and glomerular filtration rate (eGFR) were identified as significant covariates. Median (range) peritoneal/plasma AUC 0–24h ratio was 72 (45–94) %. Simulations showed that optimal dosing regimens ranged from 300 mg/kg/day (q6h over 3 hours) to 400 mg/kg/day as a continuous infusion, depending on the PK target (i.e., f T >1 × MIC or f T >4 × MIC ) and patient eGFR. In children undergoing LT, body weight and renal function explained some of the between subject variability for piperacillin PK. Higher dosing regimen combined with therapeutic drug monitoring is necessary to optimize exposure in plasma and at surgical site.

  • Modélisation pharmacocinétique et pharmacodynamique de l'adrénaline et de la noradrénaline chez l'enfant

    by Mehdi Oualha

    Les effets des catécholamines en réanimation sont peu prédictibles. La variabilité interindividuelle des observations est d’origine multifactorielle dont des facteurs pharmacocinétiques et pharmacodynamiques, dépendant de caractéristiques constitutionnelles et acquises de chaque individu. Les posologies de l’adrénaline et de la noradrénaline chez l’enfant sont extrapolées des données adultes. Pourtant l’âge est une source de grande variabilité liée au développement. Un modèle pharmaco- statistique de l’adrénaline et de la noradrénaline a été établi chez l’enfant en insuffisance circulatoire aigüe. Il a permis d’identifier des facteurs de variabilité entre les individus ainsi que de proposer des schémas de prescription des deux molécules en fonction de l’effet souhaité et des caractéristiques de l’enfant. La pharmacocinétique de l’adrénaline chez 39 enfants en prévention du syndrome de bas débit cardiaque postopératoire suivait un modèle monocompartimental. La clairance augmentait avec le poids selon le principe de l’allométrie. Les augmentations résultantes de la fréquence cardiaque et de la pression artérielle moyenne suivaient un modèle d’effet direct Emax. Elles étaient influencées par l’âge et la gravité des patients. Les augmentations de glycémie et lactatémie suivaient un modèle d’effet indirect. Pour la noradrénaline, chez 38 enfants atteints d’hypotension artérielle systémique, la pharmacocinétique était mono-compartimentale. La clairance était influencée par le poids (allométrie). L’augmentation induite de la pression artérielle moyenne suivait un modèle direct Emax. Elle était fonction de l’âge et de la gravité des patients. Les posologies de l’adrénaline et de la noradrénaline chez l’enfant devraient tenir compte du poids, de l’âge et de la gravité du patient : plus jeune est l’enfant et plus grave est son état, plus la posologie doit être élevée pour satisfaire les objectifs hémodynamiques.

  • Open Access

    Corrigenda: Pain, Agitation, Delirium, and Iatrogenic Withdrawal Syndrome Management in Children Who Are Critically Ill: Protocol for a European Clinical Practice Guideline Using the Grading of Recommendations Assessment, Development, and Evaluation Approach (Preprint)

    by Ibo MacDonald, Alexia Cavin-Trombert, Cécile Jaques, Gwenaëlle De Clifford-Faugère, Pieter A De Cock, Saskia N de Wildt, Dmytro Dmytriiev, Juliane Engel, Paola Claudia Fazio, Sylvia George, et al.

  • Open Access

    Cefepime exposure in prolonged or intermittent infusion in critically ill children

    by Marc Hobeika, Déborah Hirt, Emmanuelle Bille, Sihem Benaboud, Julie Toubiana, Pierre-Louis Léger, Jérôme Rambaud, Agathe Beranger, Delphine Callot, Sylvain Renolleau, et al.

    Introduction : Cefepime is commonly used in critically ill children for whom there is a high between subject variability. To reach the therapeutic pharmacokinetic (PK) target in critically ill patients, beta-lactams prolonged infusion seems to be the most efficient. The aim of this study was to compare cefepime exposure between prolonged and intermittent infusions in critically ill children. Methods : This prospective observational study was conducted in two pediatric intensive care units. Children with a cefepime plasma concentration measurement were included. Steady-state free residual and plateau concentrations were estimated using Bayesian forecasting. The PK target was defined as 100% f T ≥4xMIC . Exposure was compared using the minimum inhibitory concentrations (MIC) of the pathogens identified in the patients. The probability of target attainment (PTA) was also compared using various MICs. Results : Seventy-eight antibiotic courses in 75 patients were included, divided into 19 prolonged infusions and 59 intermittent infusions. Prolonged and intermittent infusions were comparable for optimal exposure (n=10/19, 53% vs n=35/59, 59%, p=0.79). Overexposure tended to be more frequent with prolonged infusion (n=8/19, 42% vs n=16/59, 27%, p=0.26), while underexposure tended to be less common with prolonged infusion (n=1/19, 5% vs n=8/59, 14%, p=0.44). Considering the wide range of MICs, the PTA was comparable for MIC < 1 mg/L, but was significantly higher for prolonged infusion for MIC ≥ 1 mg/L (pConclusion : Prolonged infusion of cefepime provides a higher PTA when MIC is ≥ 1 mg/L compared with intermittent infusion. This result suggests the superiority of prolonged infusion for high MIC bacteria.

  • Drug dosing optimization in critically ill children under continuous renal replacement therapy: from basic concepts to the bedside model informed precision dosing

    by Mehdi Oualha, Michael Thy, Naïm Bouazza, Sihem Benaboud, Agathe Béranger

    IntroductionOptimizing drug dosage in critically ill children undergoing Continuous Renal Replacement Therapy (CRRT) is mandatory and challenging, given the many factors impacting pharmacokinetics and pharmacodynamics coupled with the vulnerability of this population.Areas coveredA good understanding of the mechanisms that determine drug elimination via the CRRT technique is useful to avoid prescription pitfalls, however limited by the high between and within subject variability. The developments of population pharmacokinetic and physiologically based pharmacokinetic models derived from in-vivo and in-vitro studies, are challenging, but remain the most appropriate tool to suggest adjusted dosage regimens for every patient, throughout treatment. We searched PubMed using the search string: 'pediatrics OR children' AN 'continuous renal replacement therapy' AND 'pharmacokinetics' AND 'model informed precision dosing' AND, 'physiologically based pharmacokinetics,' AND 'therapeutic drug monitoring' until January 2024, regardless of language or publication status.Expert opinionFamiliarizing the pediatric intensivists with the therapeutic drug monitoring and providing clinicians the individualized prescribing software such as Model Informed Precision Dosing would be a significant step forward. The clinical benefit for patients remains to be demonstrated.


  • Improving cefazolin exposure in critically ill children using a population pharmacokinetic model

    by Clémence Rivaud, Mehdi Oualha, Elodie Salvador, Emmanuelle Bille, Delphine Callot, Agathe Béranger, Leo Froelicher Bournaud, Steeve Rouillon, Julie Toubiana, Sihem Benaboud, et al.

    Aims: Population pharmacokinetics (PK) models may be effective in improving antibiotic exposure with individualized dosing. The aim of the study is to assess cefazolin exposure using a population PK model in critically ill children.Methods: We conducted a single‐centre observational study including children under 18 years old who had cefazolin plasma monitoring before and after a cefazolin model implementation. The first concentration at steady state of each cefazolin course was analysed. The optimal exposure was defined by concentration values ranging from free concentration over four times the minimal inhibitory concentration (MIC) for 100% of the dosing interval to total trough or plateau concentration under 100 mg. L−1.Results: A total of 58 patients were included, of whom 39 and 19 children received conventional dosing or model‐informed dosing, respectively. Median [range] age was 2.3 [0.1–17] years old, and median weight was 14.2 [2.9–72] kg. There were more continuous infusions (CI) in the model group than in the conventional group (n = 19/19 [100%] vs. n = 23/39 [59%]). Compared to conventional dosing, model‐informed dosing provided more optimal exposure (n = 17/39 [44%] vs. n = 15/19 [79%], P = .01) and less underexposure (n = 18/39 [46%] vs. n = 2/19 [10%], P = .008), without increasing overexposure (n = 4/39 [10%] vs. n = 2/19 [11%], P = 1). Moreover, the time to C‐reactive protein decrease by 50% was significantly shorter in the model group than the conventional group (3 [0.5–13] vs. 4 [1–34]; P = .045).Conclusions: Use of individualized cefazolin model‐informed dosing improves critically ill children's exposure. Further studies are needed to assess the clinical benefit of cefazolin PK model application.


  • Open Access

    Assessment of self-perceived knowledge of key clinical pharmacology concepts and educational needs among European Paediatric Intensive Care Units: an ESPNIC survey

    by Marco Daverio, Francesca Sperotto, Elisa Poletto, Stefania Bianzina, Laura Butragueño Laiseca, Francesco Cardona, Pieter De Cock, Matthijs De Hoog, Sylvia George, Mehdi Oualha, et al.

    Background: Knowledge of clinical pharmacology concepts is essential to improve patients’ outcomes. Scarce data is available on the utilisation of these concepts in the paediatric intensive care unit (PICU). We aimed to investigate the self-perceived knowledge of clinical pharmacology concepts, educational needs and identify priorities for pharmacological research across European PICUs. Methods: From July to November 2022 an online survey was distributed to evaluate i) the self-reported knowledge, and ii) application of key pharmacology concepts in clinical practice (using a likert scale from 1 = never apply to 10 = always apply); iii) need for additional education on them; and iv) key areas for future pharmacological research. The survey was distributed to European Society of Paediatric and Neonatal Intensive Care (ESPNIC) members and other European national PICUs societies members. Results: Two-hundred-thirty-seven responses from 149 PICUs were collected. 54% of PICUs reported to have a clinical pharmacologist available for consultation during drug prescription and 65% of them regularly contact them during the prescribing process. Among clinical pharmacology concepts the parameter with the highest self-reported knowledge was half-life (99%) and the lowest were pharmacodynamics and volume-of-distribution (92%). The reported median application of these concepts in clinical practice ranged between 5/10 and 7/10. Most of the respondents reported the need for additional education on specific pharmacology concepts. Reported priorities for drug research mostly involved analgesics/sedatives (87%), antimicrobials (86%), and cardiovascular medications (55%). Conclusions: Self-reported knowledge on clinical pharmacology concepts seems good, but self-perceived clinical application may improve and most of the respondents report a need for additional education. These findings call for concerted multidisciplinary efforts to streamline education and guidelines to fill this gap.